OSU-6162
OSU-6162[edit | edit source]
OSU-6162 is a chemical compound that acts as a dopamine receptor modulator. It is of interest in the field of neuropharmacology due to its potential therapeutic effects in various neurological disorders.
Chemical Properties[edit | edit source]
OSU-6162 is a member of the piperazine class of compounds. Its chemical structure is characterized by a piperazine ring, which is a common feature in many psychoactive drugs. The compound is known for its ability to modulate the activity of dopamine receptors, particularly the D2 and D3 subtypes.
Mechanism of Action[edit | edit source]
OSU-6162 functions as a dopamine stabilizer, meaning it can either enhance or inhibit dopamine activity depending on the existing levels of dopamine in the central nervous system. This unique property makes it a candidate for treating conditions where dopamine dysregulation is a factor, such as schizophrenia, Parkinson's disease, and addiction.
Therapeutic Potential[edit | edit source]
Research into OSU-6162 has suggested its potential use in treating psychosis and cognitive dysfunction. Unlike traditional antipsychotic medications, OSU-6162 may offer benefits without the severe side effects associated with dopamine blockade, such as tardive dyskinesia and extrapyramidal symptoms.
Clinical Trials[edit | edit source]
Clinical trials have been conducted to evaluate the efficacy and safety of OSU-6162 in various patient populations. These studies aim to determine the optimal dosing regimen and to further understand the compound's pharmacokinetics and pharmacodynamics.
Related Compounds[edit | edit source]
OSU-6162 is related to other dopamine receptor modulators, such as aripiprazole and brexpiprazole, which also exhibit partial agonist activity at dopamine receptors. These compounds are part of a newer class of antipsychotics known as atypical antipsychotics.
Future Directions[edit | edit source]
Ongoing research is focused on exploring the full therapeutic potential of OSU-6162, including its effects on mood disorders and neurodegenerative diseases. The development of OSU-6162 and similar compounds represents a promising area of study in the quest for more effective and safer treatments for mental health disorders.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
